Skip to main content
Watch Insiders
AVLN filings

Corporate insider profile

Jill Carroll Filing Activity

Latest reported as Director of Avalyn Pharma Inc. (AVLN).

Purchase filings
1
Reported companies
1
Net open-market value
$5,000,004
Latest transaction
May 1, 2026

Affiliated corporations

Reported company relationships

AVLNLatest reported

Avalyn Pharma Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 1, 2026Avalyn Pharma Inc. (AVLN)DirectorOpen Market Purchase277,778$18.00$5,000,004